Is Semler Scientific Inc (SMLR) overvalued? · P/E 5.0, rev $56.3M
Semler Scientific Inc (SMLR) is a medical devices company listed on NASDAQ.
This page asks whether Semler Scientific Inc (SMLR) looks expensive on cached numbers — not a short thesis.
Latest reported SMLR revenue for 2024-12-31 was $56.3M. Net income was $40.9M. SMLR currently screens at market cap $348.3M and trailing P/E 5.0.
SMLR currently screens at market cap $348.3M and trailing P/E 5.0. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SMLR 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SMLR stock page for the full model, not this heading.
Not investment advice.